Bioceres Crop Solutions Corp.
BIOXNASDAQBasic Materials● Active
$0.43
+$0.00(+1.17%)
Market Cap$26878308
P/E Ratio—
52W High$5.155
52W Low$0.347
Bioceres Crop Solutions Corp. (BIOX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BIOX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
-$0.16
Est. -$0.05 · -220.0%
Revenue
$0.04B
Est. $0.05B · -27.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
BIOX reports quarterly as a NASDAQ-listed Agricultural Inputs company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 8, 2026 | -$0.06 | — | — | — | $0.08B | — |
| ▼ Q2 FY2026 | May 11, 2026 | -$0.05 | -$0.16 | -220.0% | $0.04B | $0.05B | -27.7% |
| ▼ Q1 FY2026 | Mar 13, 2026 | $0.07 | -$0.08 | -214.3% | $0.07B | $0.10B | -23.3% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -$0.04 | -$0.12 | -200.0% | $0.08B | $0.09B | -14.2% |
| ▲ Q2 FY2025 | May 21, 2025 | -$0.10 | -$0.02 | +80.0% | $0.06B | $0.11B | -46.7% |
| ▼ Q1 FY2025 | Feb 11, 2025 | $0.14 | $0.01 | -92.9% | $0.11B | $0.06B | +72.6% |
| ▼ Q4 FY2024 | Nov 11, 2024 | -$0.01 | -$0.09 | -800.0% | $0.09B | $0.14B | -35.3% |
| ▼ Q3 FY2024 | Sep 9, 2024 | $0.20 | -$0.03 | -115.0% | $0.12B | $0.13B | -7.6% |
Q3 FY2026
Sep 8, 2026
EPS Actual
—
EPS Est.
-$0.06
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Miss
EPS Actual
-$0.16
EPS Est.
-$0.05
EPS Surpr.
-220.0%
Revenue
$0.04B
Q1 FY2026
Mar 13, 2026Miss
EPS Actual
-$0.08
EPS Est.
$0.07
EPS Surpr.
-214.3%
Revenue
$0.07B
Q4 FY2025
Nov 12, 2025Miss
EPS Actual
-$0.12
EPS Est.
-$0.04
EPS Surpr.
-200.0%
Revenue
$0.08B
Q2 FY2025
May 21, 2025Beat
EPS Actual
-$0.02
EPS Est.
-$0.10
EPS Surpr.
+80.0%
Revenue
$0.06B
Q1 FY2025
Feb 11, 2025Miss
EPS Actual
$0.01
EPS Est.
$0.14
EPS Surpr.
-92.9%
Revenue
$0.11B
Q4 FY2024
Nov 11, 2024Miss
EPS Actual
-$0.09
EPS Est.
-$0.01
EPS Surpr.
-800.0%
Revenue
$0.09B
Q3 FY2024
Sep 9, 2024Miss
EPS Actual
-$0.03
EPS Est.
$0.20
EPS Surpr.
-115.0%
Revenue
$0.12B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2026 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Q1 FY2026 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Q4 FY2025 | $0.07 | $0.07 | $0.07 | 1 |
| Q3 FY2025 | $-0.08 | $-0.06 | $-0.05 | 2 |
| Q2 FY2025 | $0.03 | $0.07 | $0.10 | 2 |
| Q1 FY2025 | $-0.29 | $-0.13 | $0.04 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2025 | $0.1B | $0.1B | $0.1B | 3 |
| Q2 FY2025 | $0.1B | $0.1B | $0.1B | 3 |
| Q1 FY2025 | $0.1B | $0.1B | $0.1B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 11, 2026 | -220.0% | $0.47 | $0.54 | +15.48% |
| ▼ Q1 FY2026 | Mar 13, 2026 | -214.3% | $0.61 | $0.53 | -12.87% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -200.0% | $1.93 | $1.87 | -3.11% |
| ▲ Q2 FY2025 | May 21, 2025 | +80.0% | $4.65 | $4.45 | -4.30% |
| ▼ Q1 FY2025 | Feb 11, 2025 | -92.9% | $5.69 | $5.55 | -2.46% |
| ▼ Q4 FY2024 | Nov 11, 2024 | -800.0% | $6.39 | $6.48 | +1.41% |
| ▼ Q3 FY2024 | Sep 9, 2024 | -115.0% | $10.10 | $9.99 | -1.09% |
| ▼ Q2 FY2024 | May 13, 2024 | -12.5% | $12.91 | $12.35 | -4.34% |
Q2 FY2026+15.48%
Report Date
May 11, 2026
EPS Beat/Miss
-220.0%
Price Before
$0.47
Price After
$0.54
Q1 FY2026-12.87%
Report Date
Mar 13, 2026
EPS Beat/Miss
-214.3%
Price Before
$0.61
Price After
$0.53
Q4 FY2025-3.11%
Report Date
Nov 12, 2025
EPS Beat/Miss
-200.0%
Price Before
$1.93
Price After
$1.87
Q2 FY2025-4.30%
Report Date
May 21, 2025
EPS Beat/Miss
+80.0%
Price Before
$4.65
Price After
$4.45
Q1 FY2025-2.46%
Report Date
Feb 11, 2025
EPS Beat/Miss
-92.9%
Price Before
$5.69
Price After
$5.55
Q4 FY2024+1.41%
Report Date
Nov 11, 2024
EPS Beat/Miss
-800.0%
Price Before
$6.39
Price After
$6.48
Q3 FY2024-1.09%
Report Date
Sep 9, 2024
EPS Beat/Miss
-115.0%
Price Before
$10.10
Price After
$9.99
Q2 FY2024-4.34%
Report Date
May 13, 2024
EPS Beat/Miss
-12.5%
Price Before
$12.91
Price After
$12.35
Avg Beat Reaction-4.30%
Avg Miss Reaction-1.00%
Beat Rate1 / 8 quarters
Largest Move+15.48% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BIOX ends December
Bioceres Crop Solutions Corp. (BIOX) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $-0.16 — missing the analyst consensus of $-0.05 by -220.0%. The next BIOX earnings date is expected around September 1, 2026.
Each quarter, investors track BIOX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BIOX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BIOX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BIOX earnings · 5 questionsBioceres Crop Solutions Corp.'s next earnings report is expected around September 1, 2026. BIOX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BIOX historically reports after market close (AMC).
BIOX earnings datewhen is BIOX earningsBIOX next earnings datewhen does BIOX report earningsBIOX earnings calendar
▸ Source: FMP · Bioceres Crop Solutions Corp. SEC filings · US GAAP · Bioceres Crop Solutions Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026